This site uses cookies to store information on your computer. Learn more x

DSM announces management changes

Heerlen, NL, 23 Sep 2010 11:15 CEST

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management changes:

Mr. Anton Robek (1959), most recently President and CEO of DSM Melamine, will be appointed as Senior Vice President of DSM’s Emerging Business Area (EBA) DSM Bio-based Products & Services with effect from 1 January 2011. In this role he will build on the success of this EBA, formerly named DSM White Biotechnology, and drive its further commercialization as outlined in the strategy: ‘DSM in motion: driving focused growth’. Anton Robek will report to Mr. Rob van Leen, DSM’s Chief Innovation Officer.

Mr. Volkert Claassen (1953), currently Vice President DSM White Biotechnology, has been appointed Vice President Strategy & Growth Options of the DSM Innovation Center and Vice President Strategy & Partnerships of DSM Bio-based Products & Services. Volkert Claassen has very successfully built the EBA DSM White Biotechnology into a launching platform for products and services in the areas of biofuels and biochemicals. His track record and extensive network in the biotechnology industry give DSM an excellent position to take this enlarged EBA to the next level.